Disease Duration Did Not Influence the Rates of Loss of Efficacy of the Anti-TNF Therapy in Latin American Crohn's Disease Patients

Publisher： Karger

E-ISSN： 1421-9867|91|2|158-163

ISSN： 0012-2823

Source： Digestion, Vol.91, Iss.2, 2015-02, pp. : 158-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is there a future role for anti-TNF therapy in cardiovascular disease?

By Jacobsson Lennart TH   Jovinge Stefan   Turesson Carl  

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 265-269

Future Medicine

Access to resources Recommend Favorite

Effect of Anti-TNF Therapy and Vitamin D Derivatives on the Proliferation of Peripheral Blood Mononuclear Cells in Crohn's Disease

By Stio Maria   Treves Cristina   Martinesi Maria   d'Albasio Giuseppe   Bagnoli Siro   Bonanomi Andrea G.  

Digestive Diseases and Sciences, Vol. 49, Iss. 2, 2004-02 ,pp. : 328-335

Springer Publishing Company

Access to resources Recommend Favorite

Induction or Exacerbation of Psoriasis in Patients with Crohn's Disease under Treatment with Anti-TNF Antibodies

By  

Digestion, Vol. 89, Iss. 3, 2014-05 ,pp. : 209-215

Karger

Access to resources Recommend Favorite

Fibrotic Strictures and Anti-TNF-α Therapy in Crohn’s Disease

By  

Digestion, Vol. 75, Iss. 1, 2007-04 ,pp. : 22-24

Karger

Access to resources Recommend Favorite

Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease

By Rismo Renathe   Olsen Trine   Cui Guanglin   Paulssen Eyvind J.   Christiansen Ingrid   Johnsen Knut   Florholmen Jon   Goll Rasmus  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 3, 2013-03 ,pp. : 311-319

Informa Healthcare

Access to resources Recommend Favorite